In addition to their other observations in BRAF-altered melanoma, Lionarons et al. documented the potency of mutant RAC1P29S to activate a downstream transcriptional WAVE-ARP2/3-SRF/MRTF cascade, leading to de-differentiation, enhanced cancer cell survival, and therapeutic resistance [22]. Here, BRAF is linked to melanoma.